- Home
- IMCR vs TIGR Comparison
IMCR vs TIGR Comparison
Compare IMCR & TIGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- TIGR
- Stock Information
- Founded
- IMCR 2008
- TIGR 2014
- Country
- IMCR United Kingdom
- TIGR China
- Employees
- IMCR N/A
- TIGR N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- TIGR Investment Bankers/Brokers/Service
- Sector
- IMCR Health Care
- TIGR Finance
- Exchange
- IMCR Nasdaq
- TIGR Nasdaq
- Market Cap
- IMCR 1.4B
- TIGR 1.2B
- IPO Year
- IMCR 2021
- TIGR 2019
- Fundamental
- Price
- IMCR $30.52
- TIGR $8.28
- Analyst Decision
- IMCR Buy
- TIGR Buy
- Analyst Count
- IMCR 12
- TIGR 2
- Target Price
- IMCR $60.90
- TIGR $8.54
- AVG Volume (30 Days)
- IMCR 378.9K
- TIGR 6.4M
- Earning Date
- IMCR 05-07-2025
- TIGR 06-04-2025
- Dividend Yield
- IMCR N/A
- TIGR N/A
- EPS Growth
- IMCR N/A
- TIGR 74.02
- EPS
- IMCR N/A
- TIGR 0.37
- Revenue
- IMCR $310,202,000.00
- TIGR $330,737,913.00
- Revenue This Year
- IMCR $20.52
- TIGR $53.12
- Revenue Next Year
- IMCR $8.57
- TIGR $16.72
- P/E Ratio
- IMCR N/A
- TIGR $21.11
- Revenue Growth
- IMCR 24.36
- TIGR 46.64
- 52 Week Low
- IMCR $23.15
- TIGR $3.10
- 52 Week High
- IMCR $62.74
- TIGR $14.48
- Technical
- Relative Strength Index (RSI)
- IMCR 59.89
- TIGR 58.78
- Support Level
- IMCR $27.55
- TIGR $7.16
- Resistance Level
- IMCR $30.85
- TIGR $7.72
- Average True Range (ATR)
- IMCR 1.85
- TIGR 0.51
- MACD
- IMCR 0.43
- TIGR 0.12
- Stochastic Oscillator
- IMCR 89.06
- TIGR 90.46
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About TIGR UP Fintech Holding Ltd representing fifteen
UP Fintech Holding Ltd is an online brokerage firm focusing on Chinese investors. Its trading platform enables investors to trade in equities and other financial instruments on multiple exchanges of stocks and other derivatives. The company offers its customers brokerage and value-added services, including trade order placement and execution, margin financing, account management, investor education, community discussion, and customer support.